Cargando…

IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases

Background: IDO1 and COX2 have emerged as promising immunotherapy targets. It is unclear whether IDO1 and COX2 expression levels in colorectal cancer (CRC) patients with liver oligometastases could be independent predictors of overall survival (OS) and progression-free survival (PFS). The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Miaoqing, Wu, Xiaoliang, Wang, Xing, Hong, Xiangchan, Liu, Yifan, Lv, Guangzhao, Li, Cong, Pan, Zhizhong, Zhang, Rongxin, Chen, Gong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055914/ https://www.ncbi.nlm.nih.gov/pubmed/36983678 http://dx.doi.org/10.3390/jpm13030496

Ejemplares similares

TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection
por: Peng, Jianhong, et al.
Publicado: (2019)

Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study
por: Sui, Qiaoqi, et al.
Publicado: (2019)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis
por: Lin, Junzhong, et al.
Publicado: (2017)

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
por: Wang, Fulong, et al.
Publicado: (2023)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Programmed death-ligand 1 expression in the tumour stroma of colorectal liver oligometastases and its association with prognosis after liver resection
por: Peng, Jian-Hong, et al.
Publicado: (2020)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
por: Chen, Qichen, et al.
Publicado: (2021)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

The Impact of Preoperative Inflammatory Markers on the Prognosis of Patients Undergoing Surgical Resection of Pulmonary Oligometastases
por: Londero, Francesco, et al.
Publicado: (2020)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

Oligometastases in prostate cancer: Ablative treatment
por: Palacios-Eito, Amalia, et al.
Publicado: (2019)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

High Spy1 expression predicts poor prognosis in colorectal cancer
por: Jin, Qin, et al.
Publicado: (2018)

Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis
por: Peng, Jianhong, et al.
Publicado: (2017)

Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
por: Cao, Liyu, et al.
Publicado: (2021)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Oligometastases: history and future vision of breast cancer
por: Niibe, Yuzuru, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Jingu, Keiichi, et al.
Publicado: (2018)

Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
por: Li, Shuai, et al.
Publicado: (2019)

IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
por: Jiao, Ruidi, et al.
Publicado: (2020)

IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer
por: Deng, Yu, et al.
Publicado: (2022)

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors
por: Ji, Xiaoqin, et al.
Publicado: (2021)

Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
por: Niibe, Yuzuru, et al.
Publicado: (2012)

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer
por: Tabata, Ken-ichi, et al.
Publicado: (2012)

Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
por: Niibe, Yuzuru, et al.
Publicado: (2010)

Helical tomotherapy for spine oligometastases from gastrointestinal malignancies
por: Choi, Yunseon, et al.
Publicado: (2011)

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes—A Review
por: Matsushita, Haruo, et al.
Publicado: (2018)

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease
por: AlGhamdi, Hamza, et al.
Publicado: (2022)

Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis
por: Chen, Jinbin, et al.
Publicado: (2018)

Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis
por: Al-Maghrabi, Basim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jie91onp0s7kpc6a6g21lpudsi